Abstract
A series of cholesterylated carboxylic acids L1-L6 as the hepatic targeting ligands were synthesized for gene delivery. The characteristics of those ligands is cholesterylated ones with different spacer lengths with oigo(ethylene glycol) units. We designed two different routes to synthesize L1-L6 from alcohol 3 under mild condition in moderate yield.
Keywords: Cholesterylated carboxylic acid, oligo(ethylene glycols), targeting ligand, gene delivery
Letters in Organic Chemistry
Title: Synthesis of Cholesterylated Carboxylic Acids with Oligo(Polyethylene Glycols) Units for Gene Delivery
Volume: 3 Issue: 12
Author(s): Xiaochun Wu, Yong Wu, Li Hai and Ying Bao
Affiliation:
Keywords: Cholesterylated carboxylic acid, oligo(ethylene glycols), targeting ligand, gene delivery
Abstract: A series of cholesterylated carboxylic acids L1-L6 as the hepatic targeting ligands were synthesized for gene delivery. The characteristics of those ligands is cholesterylated ones with different spacer lengths with oigo(ethylene glycol) units. We designed two different routes to synthesize L1-L6 from alcohol 3 under mild condition in moderate yield.
Export Options
About this article
Cite this article as:
Wu Xiaochun, Wu Yong, Hai Li and Bao Ying, Synthesis of Cholesterylated Carboxylic Acids with Oligo(Polyethylene Glycols) Units for Gene Delivery, Letters in Organic Chemistry 2006; 3 (12) . https://dx.doi.org/10.2174/157017806779468004
DOI https://dx.doi.org/10.2174/157017806779468004 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Depression and its Relation with Uncontrolled Hypertension and Increased Cardiovascular Risk
Current Hypertension Reviews Physiology of Islet Engraftment
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View
Current Diabetes Reviews Advancement in Vaccinology: New Era in Formulation Strategies
Current Drug Therapy Periodontal Disease and Periodontal Tissue Regeneration
Current Stem Cell Research & Therapy Physiological and Pharmacological Regulation of Hepatic 3-Hydroxy-3- Methylglutaryl Coenzyme A Reductase
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
Current HIV Research Patent Selections:
Recent Patents on Drug Delivery & Formulation Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents
Mini-Reviews in Medicinal Chemistry The Association Between the Chronic Use of Non-Steroidal Anti- Inflammatory Drugs and Oxidative and Inflammatory Markers in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Complement Components, C3 and C4, and the Metabolic Syndrome
Current Diabetes Reviews Oleic Acid in Olive Oil: From a Metabolic Framework Toward a Clinical Perspective
Current Pharmaceutical Design The Effects of Sevoflurane or Remifentanil on the Stress Response to Surgical Stimulus
Current Pharmaceutical Design Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition
Current Drug Targets Acknowledgements to Reviewers:
Current Diabetes Reviews Applications of Stem Cell Therapy for Physeal Injuries.
Current Stem Cell Research & Therapy The Effects of Current Therapies on Airway Remodeling in Asthma and New Possibilities for Treatment and Prevention
Current Molecular Pharmacology Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer
Current Pharmaceutical Design Supramolecular Nanomedicine - An Overview
Current Drug Targets Novel Adjunctive Therapies for the Treatment of Tuberculosis
Current Molecular Medicine